Irmler and collaborators in 2007 showed that IFNγ-/- AIA mice presented an increased inflammatory response, and treatment with the recombinant murine IFNγ into the knee joint during arthritis inducing was capable to attenuate the joint injury [29]. Here, IFNG is linked to arthritic joint disease.